Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
复制标题
DOI:
--
复制
发表时间:
2000-08
期刊:
影响因子:
11.2
通讯作者:
Hiromu Suzuki;F. Itoh;M. Toyota;T. Kikuchi;H. Kakiuchi;K. Imai
中科院分区:
文献类型:
--
作者:
Hiromu Suzuki;F. Itoh;M. Toyota;T. Kikuchi;H. Kakiuchi;K. Imai
The cell cycle checkpoint plays an important role in maintaining the integrity of cells. Recently, one of the 14-3-3 protein family members, 14-3-3sigma, was shown to be regulated by p53 and to play a role in the G2-M-phase checkpoint. To determine whether 14-3-3sigma is inactivated in human cancers, the methylation status of the 5' region of 14-3-3sigma was investigated in a series of gastric, colorectal, and hepatocellular cancer cell lines. Of 22 cell lines examined, 6 showed aberrant methylation. The methylation status of 14-3-3sigma was found to be correlated with loss of expression, which was restored by 5-aza-2'-deoxycytidine treatment. Furthermore, normal G2 arrest after DNA damage was not demonstrated in the cell lines with methylation. In primary gastric cancers, 14-3-3sigma hypermethylation was observed frequently in 26 of 60 (43%) cases and observed more frequently in poorly differentiated adenocarcinomas (P = 0.0017). Our findings suggest that 14-3-3sigma is inactivated by aberrant methylation of the 5' region in various human cancers and that it might play an important role in the development of undifferentiated gastric cancers.